Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Pleural Diseases 2Mesothelioma, Malignant 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Lymphoid Interstitial Pneumonia 1

Interventions

Cisplatin 9Cetuximab 9Radiotherapy, Intensity-Modulated 7Everolimus 4Docetaxel 3Carboplatin 3Biopsy 3130-nm albumin-bound paclitaxel 3Ultrasonography 2Taxes 2Radiotherapy 2Radiation 2Photochemotherapy 2Paclitaxel 2Microarray Analysis 2Immunohistochemistry 2Gene Expression Profiling 2Fluorouracil 2Erlotinib Hydrochloride 2Cryosurgery 2Albumin-Bound Paclitaxel 21-phenyl-3,3-dimethyltriazene 2temoporfin 1talactoferrin alfa 1sargramostim 1pimonidazole 1pembrolizumab 1Zinc Oxide 1X-Rays 1Vaccinium myrtillus extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Tongue Neoplasms × Trioxsalen × Clear all
NCT02068157 2017-10-11

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Terminated
3 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡